The post ETH to Benefit as Stablecoins Reach $300B by 2025 Under GENIUS Act, Grayscale Says appeared on BitcoinEthereumNews.com. COINOTAG News reports that on DecemberThe post ETH to Benefit as Stablecoins Reach $300B by 2025 Under GENIUS Act, Grayscale Says appeared on BitcoinEthereumNews.com. COINOTAG News reports that on December

ETH to Benefit as Stablecoins Reach $300B by 2025 Under GENIUS Act, Grayscale Says

COINOTAG News reports that on December 19, Grayscale published a post on X outlining a constructive stablecoin outlook through 2025. The note cites a projected total supply near $300 billion and an average monthly transaction volume around $1.1 trillion, signaling heightened on-chain activity in the sector.

With the GENIUS Act (Stablecoin Genius Act) now advancing, rising stablecoin adoption could channel greater transaction flow to leading blockchains, including ETH, TRX, BNB, and SOL, bolstering liquidity and network throughput.

Infrastructure players such as Chainlink and emerging networks like XPL stand to benefit from broader stablecoin rails, as developers integrate robust oracle services and interoperable networks to support cross-chain activity and DeFi liquidity provisioning.

Source: https://en.coinotag.com/breakingnews/eth-to-benefit-as-stablecoins-reach-300b-by-2025-under-genius-act-grayscale-says

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,960.45
$2,960.45$2,960.45
-0.19%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.